New Full Professors

A list of faculty members appointed by the May 15, 2017 Faculty of Medicine event are listed below.  For a complete listing of all appointed professors during a given academic year, please click here

Appointed since December 15th, 2016
Faculty of Medicine reception held on May 15th, 2017

Dr. Armstrong

Scott A. Armstrong, M.D., Ph.D.
Dr. Armstrong is Professor of Pediatrics at the Dana-Farber Cancer Institute where he is Chair of the Department of Pediatric Oncology. He is a leader in cancer research whose research on stem cell in cancer and chromatin biology have led to several novel insights into the origins of leukemia. This work has prompted the development of new therapies that are now being tested in adults and children with leukemia.

Dr. Mercedes

Mercedes C. Becerra, Sc.D.
Dr. Becerra is Professor of Global Health and Social Medicine at Harvard Medical School. She has conducted seminal research on the epidemiology of tuberculosis in children and the transmission of drug-resistant tuberculosis within households. Her work has led to an improved understanding of the global unmet need for the diagnosis and treatment of children with tuberculosis, as well as strategies to deliver care to families exposed to drug-resistant tuberculosis.

Dr. Bukstein

Oscar G. Bukstein, M.D.
Dr. Bukstein is Professor of Psychiatry at Boston Children’s Hospital where he is Vice-Chair and Associate Psychiatrist-in-Chief and the Training Director of the Child and Adolescent Psychiatry Fellowship. His clinical and research expertise is in treating youth with substance use and disruptive behavior disorders. He has been instrumental in developing national practice parameters and clinical guidelines for the field of child and adolescent psychiatry.

Dr. Cummings

Richard D. Cummings, Ph.D.
Dr. Cummings is Professor of Surgery at the Beth Israel Deaconess Medical Center where he is the Director of the HMS Center for Glycosciences. His research is focused on understanding the structures and functions of complex carbohydrates and their roles in diverse pathways, including development, hemostasis, hematopoiesis, inflammatory conditions, cancer, infections, and immune interactions. His work has led to new treatments for multiple diseases, including inflammatory disorders and cancer, and new ways to manipulate cellular glycomes.

Dr. Doherty

Gerard M. Doherty, M.D.
Dr. Doherty is Professor and Chief of the Department of Surgery at Brigham and Women's Hospital. He is an accomplished endocrine surgeon and has contributed broadly to the improvement of care for patients with tumors of the thyroid, parathyroid, pancreas and adrenal glands. He has also been deeply involved in developing national standards of surgical education for medical students and residents.

Dr. Ebert

Benjamin L. Ebert, M.D., D.Phil.
Dr. Ebert is Professor of Medicine at Brigham and Women’s Hospital, an Institute Member of the Broad, and Director of the Dana-Farber/Brigham and Women’s Leukemia Center. His research focuses on the genetics, biology, and therapy of myeloid malignancies. This work has led to the characterization of clonal hematopoiesis as a pre-malignant state for hematologic malignancies and elucidation of the mechanism of action of lenalidomide and related molecules that induce degradation of specific proteins.

Dr. Fasano

Alessio Fasano, M.D.
Dr. Fasano is Professor of Pediatrics at Massachusetts General Hospital where he is Director of the Center for Celiac Research and Treatment and the Mucosal Immunology and Biology Research Center. He is a pioneer in the recognition and treatment of celiac disease and other gluten-related disorders. His basic research is focused on bacterial pathogenesis, the composition of the gut microbiome and its function in health and disease, while his translational science is focused on the role of impaired intestinal barrier function in the pathogenesis of autoimmune and inflammatory diseases.

Dr. Green

Robert C. Green, M.D., M.P.H.
Dr. Green is Professor of Medicine at Brigham and Women’s Hospital where he directs the Genomes2People Research Program. He is a recognized leader in translational genomics and health outcomes, designing empirical trials to understand the medical, behavioral and economic impact of genetic testing. His research has led to new practice policies around the disclosure and sharing of genetic information and accelerated the implementation of genomic medicine.

Dr. Greenberg

Steven A. Greenberg, M.D., M.S.
Dr. Greenberg is Professor of Neurology at Brigham and Women’s Hospital. His clinical and research interests are focused on understanding the pathogenesis of and developing therapeutics for autoimmune muscle diseases. He has developed diagnostics and candidate therapeutics in clinical development for autoimmunity and oncology.

Dr. Medina

Manuel Hidalgo Medina, M.D., Ph.D.
Dr. Hidalgo Medina is Professor of Medicine at the Beth Israel Deaconess Medical Center where he is the Chief of the Division of Hematology and Oncology and the Director of the Rosenberg Cancer Center. His work focuses on the treatment of pancreatic cancer a disease for which he has contributed new animal models and the development of FDA approved drugs. His more recent efforts involve the development of new strategies for precision medicine and immunotherapy in this disease.

Dr. Hornick

Jason L. Hornick, M.D., Ph.D.
Dr. Hornick is Professor of Pathology at Brigham and Women's Hospital where he is Director of Surgical Pathology. He is a recognized leader in soft tissue tumor, gastrointestinal pathology, and diagnostic immunohistochemistry. His work has focused on developing protein-based diagnostic biomarkers for soft tissue tumors that correlate with molecular genetic alterations.

Dr. Lee

Grace M. Lee, M.D., M.P.H.
Dr. Lee is Professor of Population Medicine at the Harvard Pilgrim Health Care Institute where she serves as Director of the Center for Healthcare Research in Pediatrics. She also serves in multiple leadership roles at Boston Children’s Hospital. Her research focuses on generating the evidence needed to support U.S. vaccine policy, evaluating the health and economic impact of value-based purchasing policies on patient outcomes, and developing national quality metrics and interventions to optimize care provided to neonates and children. This work has informed regulatory decision-making and generated novel paradigms for surveillance and prevention in pediatric populations.

Dr. Leichtner

Alan M. Leichtner, M.D., M.S.
Dr. Leichtner is Professor of Pediatrics at Boston Children’s Hospital where he is the Clinical Vice Chair of the Department of Medicine and Chief Medical Education Officer. His clinical and research interests in pediatric gastroenterology focus on inflammatory disorders of the intestine in children. His work has led to improvements in the diagnosis and management of childhood inflammatory bowel disease and celiac disease.

Dr. Marshall

Audrey C. Marshall, M.D.
Dr. Marshall is a Professor of Pediatrics at Boston Children’s Hospital, where she is the Chief of Invasive Cardiology and Director of the Advanced Fetal Care Center. As an interventional cardiologist, her research is in the field of therapeutic and device-based interventions for the fetus and child with congenital heart disease. She has described novel, minimally invasive procedures and techniques, which have been adopted by teams treating rare cardiac defects.

Dr. Meyer

Gregg S. Meyer, M.D., M.Sc., S.M.
Dr. Meyer is Professor of Medicine at Massachusetts General Hospital and is the Chief Clinical Officer of the Partners Healthcare System. His career has been focused on the intersection between clinical medicine for individuals, healthcare delivery for populations, the policies that guide them, the operations and leadership that support them, and the research with which they are informed. His work has contributed to the measurement and improvement of healthcare quality and patient safety.

Dr. Murray

Martha M. Murray, M.D.
Dr. Murray is Professor of Orthopedic Surgery at Boston Children's Hospital. Her research is focused on improving the care of patients with injuries to the anterior cruciate ligament (ACL) by defining the mechanisms behind the failure of the ligament to heal, designing tissue-engineering strategies to address the identified pathologies and translating those technologies to clinical trials. Her work has shifted the field of ACL research from a focus on surgical removal and replacement of the ligament toward repair and regeneration of this important knee structure.

Dr. Nahrendorf

Matthias Nahrendorf, M.D., Ph.D.
Dr. Nahrendorf is Professor of Radiology at Massachusetts General Hospital where he directs the Mouse Imaging Program. His laboratory investigates the cellular and molecular processes in ischemic heart disease. In particular, he focuses on myeloid cells, the hematopoietic system and development of diagnostic tools.

Dr. Nielsen

G. Petur Nielsen, M.D.
Dr. Nielsen is Professor of Pathology at Massachusetts General Hospital where he is Director of Bone and Soft Tissue Pathology and of Electron Microscopy. He is recognized as a leader in bone and soft tissue pathology. His research has focused on the clinicopathologic features and genetic analysis of neoplastic and non-neoplastic diseases and of bone and soft tissue.

Dr. Nucci

Marisa R. Nucci, M.D.
Dr. Nucci is Professor of Pathology at the Brigham and Women's Hospital and Director of the Pathology Residency Training Program. She is a well-recognized authority in the diagnosis of mesenchymal neoplasia of the female genital tract. Her research has helped re-classify tumors according to their histopathologic appearance and underlying genetic abnormality into clinically relevant groups amenable to targeted therapy.

Dr. Owens

Judith A. Owens, M.D.
Dr. Owens is Professor of Neurology at Boston Children’s Hospital where she is the Director of Sleep Medicine. Her particular research interests are in the neurobehavioral and health consequences of sleep problems in children and adolescents, sleep health education, and cultural and psychosocial issues impacting on sleep. Her research has contributed significantly to the development of public policy regarding sleep-related interventions to improve youth health and safety, including serving as lead author of the American Academy of Pediatrics 2014 Policy Statement on healthy school start times.

Dr. Park

Peter J. Park, Ph.D.
Dr. Park is Professor of Biomedical Informatics at Harvard Medical School where he is the Director of the PhD program in Bioinformatics and Integrative Genomics. His research is focused on computational approaches to understanding genetic and epigenetic mechanisms underlying disease processes. His work has led to new insights in mutational processes in cancer and other diseases as well as many algorithms that are used by research groups worldwide.

Dr. Partridge

Ann H. Partridge, M.D., M.P.H.
Dr. Partridge is Professor of Medicine at the Dana-Farber Cancer Institute and Director of the Adult Survivorship Program and the Program for Young Women with Breast Cancer. Her clinical and research efforts focus on the unique issues facing young women with breast cancer ranging from differences in tumor and host factors, to psychosocial and survivorship concerns. Her work has contributed to the understanding of fertility and ovarian reserve after breast cancer, and has lead to changes in how fertility risk and fertility preservation are routinely approached in the care of young survivors.

Dr. Patel

Vikram H. Patel, Ph.D., M.B., B.S.
Vikram Patel is Professor of Global Health and Social Medicine at Harvard Medical School. His research has focused on the epidemiology of mental disorders in the global context and their association with poverty and social disadvantage. He has pioneered the use of community resources for the delivery of interventions to integrate mental healthcare with treatment for other chronic diseases. His work has resulted in improved access to mental health resources, informed the design of health-care interventions and increased the effectiveness of health services globally.

Dr. Plotkin

Scott R. Plotkin, M.D., Ph.D.
Dr. Plotkin is Professor of Neurology at Massachusetts General Hospital where he is the Director of Cancer Neurology. His clinical and research interests have focused on developing targeted therapies for patients with neurogenetic syndromes including neurofibromatosis (NF)-1, NF2, and schwannomatosis. His work established the efficacy of bevacizumab (Avastin) treatment for patients with NF2 and has led to the worldwide use of this drug for NF2 patients with hearing loss.

Dr. Pomahac

Bohdan Pomahac, M.D.
Dr. Pomahac is Professor of Surgery at Brigham and Women’s Hospital. He is a pioneer in vascularized composite allotransplantation that includes transplantation of hands and face including the first three full-face transplants in the US. He is currently focused on studying clinical and immunological outcomes of the allografts, and preservation of tissue viability by portable extracorporeal membrane oxygenation (ECMO) machines.

Dr. Preffer

Frederic I. Preffer, Ph.D.
Dr. Preffer is Professor of Pathology at Massachusetts General Hospital where he is the Medical Director of the Immunopathology Unit and Director of the Flow & Imaging Cytometry Research Cores. His work has covered many areas of research including bone and solid organ transplantation, stem cells and the advancement of flow cytometry in the diagnosis of hematopoietic malignancies. He is currently focused on incorporating mass flow cytometry into both research and diagnostic dimensions.

Dr. Price

Julie C. Price, Ph.D.
Dr. Price is Professor of Radiology at Massachusetts General Hospital and Director of PET Pharmacokinetic Modeling at the MGH/HST Martinos Center for Biomedical Imaging. Her expertise is in quantitative PET methods for translational imaging of protein targets that includes studies of aging, neuropsychiatric disorders, and neurodegeneration. Her research has contributed to biomarker validation for early detection and longitudinal evaluation of Alzheimer’s disease and related disorders.

Dr. Raje

Noopur S. Raje, M.D.
Dr. Raje is Professor of Medicine at Massachusetts General Hospital where she is the director of the Center for Multiple Myeloma. She is a physician scientist with a primary focus on multiple myeloma and related plasma cell disorders. She has focused on developing new promising therapies including efforts that are aimed at identifying cellular signaling pathways that contribute to the survival and proliferation of myeloma cells in the bone environment.

Dr. Shifren

Jan L. Shifren, M.D.
Dr. Shifren is Professor of Obstetrics, Gynecology and Reproductive Biology at Massachusetts General Hospital and where she is the Director of the Midlife Women’s Health Center. Her clinical and research interests focus on improving the health and quality of life of midlife women. Her research has contributed to the understanding of the role of androgen therapy in the treatment of sexual dysfunction in postmenopausal women.

Dr. Taveras

Elsie M. Taveras, M.D., M.P.H.
Dr. Taveras is Professor of Pediatrics at Massachusetts General Hospital where she is Chief of the Division of General Academic Pediatrics and Director of Pediatric Population Health Management. Her main focus of research is understanding determinants of obesity in women and children and developing interventions to prevent obesity and chronic diseases, especially in underserved populations. She has published extensively on risk factors for childhood obesity in the pregnancy, infancy, and early childhood periods, and has led many influential studies on infant feeding, maternal-child feeding practices accelerated infant weight gain, and insufficient sleep.

Dr. Tseng

Jennifer F. Tseng, M.D., M.P.H.
Dr. Tseng is Professor of Surgery at the Beth Israel Deaconess Medical Center where she is Chief of the Division of Surgical Oncology and Clinical Co-Director of the BIDMC Cancer Center. She is a surgical oncologist and gastrointestinal surgeon whose practice focuses on the upper GI tract. She founded and codirects Surgical Outcomes Analysis & Research (SOAR), a clinical and outcomes research institute, and has focused her research on developing models for cancer treatment sequencing strategies and cancer biomarkers.

Dr. Turner

Jerrold R. Turner, M.D., Ph.D.
Dr. Turner is Professor of Pathology and Medicine at Brigham and Women's Hospital where he is Senior Pathologist for Gastrointestinal Pathology. His research is focused on defining the molecular mechanisms by which mucosal barriers are established and maintained, characterizing the impact of specific forms of barrier regulation on homeostasis and disease pathogenesis, and developing novel therapeutics that restore mucosal function. This has led to new paradigms of barrier regulation that have advanced our understanding of mucosal physiology and pathophysiology.

Dr. Van Dyke

Thomas E. Van Dyke, Ph.D., D.D.S.
Dr. Van Dyke is Professor of Oral Medicine, Infection and Immunity at the Harvard School of Dental Medicine and Forsyth Institute where he is Vice President for Clinical and Translational Research. His research focuses on the discovery of the molecular mechanisms that regulate inflammatory events during periodontitis and other infectious and inflammatory bone diseases with emphasis on resolution of inflammation. His work has led to clinical trials of mediators of active resolution for the treatment of this and other inflammatory diseases.

Dr. Yun

Seok-Hyun “Andy” Yun, Ph.D.
Dr. Yun is Professor of Dermatology at Massachusetts General Hospital where he is the Director of the Harvard-MIT Summer Institute for Biomedical Optics. He is a recognized innovator in the fields of optical imaging, medical devices, and photomedicine. His work has led to the invention of frequency-domain optical coherence tomography, microscopy, and cell lasers.